Home / Uncategorized / Accenture Named a Leader for Drug Safety Industry Survey; Alan Louie Comments

Accenture Named a Leader for Drug Safety Industry Survey; Alan Louie Comments

accenture_ExecutiveBizAccenture has won a leadership position position in the most recent IDC Health Insights report, which evaluates drug safety services providers in the life sciences industry.

The “WHAT IDC MarketScape: Worldwide Life Sciences Drug Safety Services 2013 Vendor Assessment” report assessed 10 firms by using both qualitative and quantitative metrics under the the IDC MarketScape model, Accenture said Monday.

“Accenture’s market-leading revenue in the drug safety services space, solid customer base with both top pharma and emerging life sciences companies, and strong emphasis on IP development makes the company a formidable competitor in drug safety,” said Alan Louie, research director for clinical development strategy and technology at IDC Health Insights.

IDC Health Insights defines excellence in drug safety services based on service-oriented scope of services, service offerings for business process outsourcing, resources and infrastructure diversity in delivering services, drug safety services outsourcing portfolios, project leaders and teams and customer satisfaction.

Follow me on Facebook

Check Also

Data Systems Analysts Secures Spot Under Navy SeaPort-e IDIQ

Data Systems Analysts has been awarded a position under the U.S. Navy‘s SeaPort-e indefinite delivery/indefinite …

Leave a Reply

Your email address will not be published. Required fields are marked *